Prospects for intervention in gastric carcinogenesis: Reversibility of gastric atrophy and intestinal metaplasia

Gut

Volumn 49, Issue 1, 2001, Pages 2-4

  Dixon, M F ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRITIS; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

ACHLORHYDRIA; ASCORBIC ACID; BETA CAROTENE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METAPLASIA; PHENOTYPE; PRECANCEROUS CONDITIONS; REMISSION INDUCTION; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0034962222     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.1.2     Document Type: Review

References (31)

1. A model for gastric cancer epidemiology
2. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: Studies in asymptomatic Japanese adults
3. Long-term symptom patterns, endoscopic findings, and gastric histology in Helicobacter pylori-infected and uninfected patients
4. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis
5. Active autoimmune gastritis without total atrophy of the glands
6. Mouse mammary tumor virus superantigens and murine autoimmune gastritis
7. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis
8. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma
9. The mucous neck cell in the human gastric corpus: A distinctive, functional cell lineage
10. Oxidative DNA damage accumulation in gastric carcinogenesis
11. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy
12. Epithelial metaplasia and the second anatomy
13. Stem cells in epithelial tissues
14. Homeodomain proteins and cell phenotype
15. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium
16. Molecular biology of gastric cancer
17. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia
18. Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers
19. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia
20. Reversible drug-induced oxyntic atrophy in rats
21. Fractographic study on the growth and multiplication of the gastric gland of the hamster
22. Significant improvement of atrophy after eradication therapy in atrophic body gastritis
23. Role of T helper 2 cells in intestinal goblet cell hyperplasia in mice infected with Trichinella spiralis
24. Carcinogenesis and progression of human gastric cancer
25. Genetic and epigenetic alterations in carcinogenesis
26. Gastric precancerous process in a high risk population: Cohort follow-up
27. Helicobacter pylori infection and chronic gastric acid hyposecretion
28. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication
29. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study
30. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy
31. Preventing cancer by disrupting progression of precancerous lesions